Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,8,0.95 [0.9-1.01],0.102061776621629,cis
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,5,0.95 [0.89-1.02],0.170172762733734,cis
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,8,1.02 [0.92-1.13],0.712428857000385,cis
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,8,0.99 [0.95-1.04],0.814394383269402,cis
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Wald ratio,1,1.15 [0.52-2.56],0.727085328833724,trans
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Wald ratio,1,0.79 [0.17-3.71],0.763579904958795,trans
GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Wald ratio,1,1.09 [0.55-2.15],0.804145130701221,trans
